In a new systematic review in JAMA Neurology, Michigan Medicine researchers found reason to further explore the surprising effects of zolpidem that have been observed outside the scope of its primary Food and Drug Administration approval. “We saw a dramatic effect in a small amount of patients with a variety of conditions,” says Martin “Nick” Bomalaski,...